Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionAntibody-drug conjugate (ADC) targeted to soluble guanylyl cyclase C (GCC; GUCY2C)
Molecular Target Guanylate cyclase C (GCC) (GUCY2C)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today